Skip to content

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04232566
Enrollment
60
Registered
2020-01-18
Start date
2022-02-20
Completion date
2027-12-30
Last updated
2026-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Inflammation, NASH - Nonalcoholic Steatohepatitis, Obesity, Morbid

Keywords

obesity, nash, adipose tissue inflammation, insulin resistance

Brief summary

This study is being done to better understand the relationship between inflammation in adipose tissue (AT), abnormal deposition of fat around the liver and how this affects its appearance and function and ultimately insulin resistance.

Interventions

PROCEDUREBariatric surgery

Evaluate liver fibrosis by elastography before gastric bypass surgery.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Undergoing gastric bypass surgery * Confirmed AUROC F=0 or F\>2 liver fibrosis * Age 30-70 years * BMI greater than 40 kg/m2 * Negative pregnancy test (female only) * Lab Values: Normal TSH

Exclusion criteria

* Autoimmune diseases * Hepatitis B or C positive * Heavy alcohol use * Active smoking history * Active cancer history * History of asthma * History of COPD * Taking Plavix or Coumadin * Blood donation within past 2 months * Glucocorticoid Therapy * Taking antihistamine on regular basis

Design outcomes

Primary

MeasureTime frameDescription
Liver fibrosisBaselineevaluate the liver fibrosis by elastography before surgical intervention
Adipose tissue inflammationBaselineEvaluate markers of adipose tissue inflammation by mRNA levels

Countries

United States

Contacts

CONTACTKeegan M Stewart
stewart.keegan@mayo.edu480-301-4164
PRINCIPAL_INVESTIGATORElena Anna O De Filippis

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026